{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:16Z","timestamp":1792788496802,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Roy L. Schneider Endowment","id":[{"id":"https:\/\/ror.org\/0229evh14","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-20101-9","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:19:07Z","timestamp":1782973147000},"page":"9141-9151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pregnancy-Associated Breast Cancer: A Trimester and Subtype Based Clinical Decision Framework for the Surgeon and Surgical Trainee"],"prefix":"10.1245","volume":"33","author":[{"given":"Hemanth","family":"Venkatesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Castro Gierach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Kanzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Tee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quyen","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"1","key":"20101_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/archsurg.138.1.91","volume":"138","author":"JC Woo","year":"2003","unstructured":"Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy: a literature review. Arch Surg. 2003;138(1):91\u20138.","journal-title":"Arch Surg."},{"issue":"19","key":"20101_CR2","first-page":"4305","volume":"115","author":"TM-L Andersson","year":"2009","unstructured":"Andersson TM-L, Johansson ALV, Hsieh C-C, Cnattingius S, Lambe M. Breast cancer during pregnancy and lactation: a population-based study. Cancer. 2009;115(19):4305\u201312.","journal-title":"Cancer."},{"issue":"1","key":"20101_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/AOG.0b013e31817c4ebc","volume":"112","author":"AO Rodriguez","year":"2008","unstructured":"Rodriguez AO, Chew H, Cress R, Xing G, McElvy S, Danielsen B, Smith L. Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol. 2008;112(1):71\u20138.","journal-title":"Obstet Gynecol."},{"issue":"4","key":"20101_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3390\/diagnostics13040604","volume":"13","author":"F Galati","year":"2023","unstructured":"Galati F, Magri V, Arias-Cadena PA, et al. Pregnancy-associated breast cancer: a diagnostic and therapeutic challenge. Diagnostics (Basel). 2023;13(4):604. https:\/\/doi.org\/10.3390\/diagnostics13040604.","journal-title":"Diagnostics (Basel)."},{"issue":"3","key":"20101_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1200\/OP-24-00867","volume":"21","author":"M Kesireddy","year":"2025","unstructured":"Kesireddy M, Krishnamurthy J. Pregnancy-associated breast cancer: key concepts for optimizing diagnosis and treatment. JCO Oncol Pract. 2025;21(3):275\u20137. https:\/\/doi.org\/10.1200\/OP-24-00867.","journal-title":"JCO Oncol Pract."},{"issue":"suppl 10","key":"20101_CR6","doi-asserted-by":"publisher","first-page":"x231","DOI":"10.1093\/annonc\/mds324","volume":"23","author":"AM Thompson","year":"2012","unstructured":"Thompson AM, Moulder-Thompson SL. Neoadjuvant treatment of breast cancer. Ann Oncol. 2012;23(suppl 10):x231\u20136. https:\/\/doi.org\/10.1093\/annonc\/mds324.","journal-title":"Ann Oncol."},{"issue":"3","key":"20101_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1161\/ATVBAHA.109.184127","volume":"29","author":"AH James","year":"2009","unstructured":"James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol. 2009;29(3):326\u201331. https:\/\/doi.org\/10.1161\/ATVBAHA.109.184127.","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"3","key":"20101_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bjae.2022.12.001","volume":"23","author":"BD Brakke","year":"2023","unstructured":"Brakke BD, Sviggum HP. Anaesthesia for non-obstetric surgery during pregnancy. BJA Educ. 2023;23(3):78\u201383. https:\/\/doi.org\/10.1016\/j.bjae.2022.12.001.","journal-title":"BJA Educ."},{"issue":"9","key":"20101_CR9","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4103\/ija.IJA_463_18","volume":"62","author":"GL Ravindra","year":"2018","unstructured":"Ravindra GL, Madamangalam AS. Anaesthesia for non-obstetric surgery in obstetric patients. Indian J Anaesth. 2018;62(9):710\u20136.","journal-title":"Indian J Anaesth."},{"issue":"suppl 1","key":"20101_CR10","doi-asserted-by":"publisher","first-page":"i72","DOI":"10.1093\/bja\/aer343","volume":"107","author":"E Reitman","year":"2011","unstructured":"Reitman E, Flood P. Anaesthetic considerations for non-obstetric surgery during pregnancy. Br J Anaesth. 2011;107(suppl 1):i72\u20138. https:\/\/doi.org\/10.1093\/bja\/aer343.","journal-title":"Br J Anaesth."},{"key":"20101_CR11","first-page":"e64","volume":"33","author":"F Amant","year":"2013","unstructured":"Amant F, Van Calsteren K, Halaska MJ, et al. Management of cancer during pregnancy. ASCO Educ Book. 2013;33:e64\u201370.","journal-title":"ASCO Educ Book."},{"key":"20101_CR12","unstructured":"Rosenberg R, Garber J. Breast cancer in pregnancy. In: Edge SB, Compton CC, eds. UpToDate. Wolters Kluwer; 2021."},{"issue":"14","key":"20101_CR13","doi-asserted-by":"publisher","first-page":"7517","DOI":"10.3390\/ijms25147517","volume":"25","author":"K Dvir","year":"2024","unstructured":"Dvir K, Giordano S, Leone JP. Immunotherapy in breast cancer. Int J Mol Sci. 2024;25(14):7517. https:\/\/doi.org\/10.3390\/ijms25147517.","journal-title":"Int J Mol Sci."},{"key":"20101_CR14","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Adolescent and Young Adult (AYA) Oncology. Version 1.2026. Published 2025. Accessed March 2025. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aya.pdf"},{"issue":"3","key":"20101_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1200\/JCO-25-02115","volume":"44","author":"AW Loren","year":"2026","unstructured":"Loren AW, Lacchetti C, Amant F, et al. Management of cancer during pregnancy: ASCO guideline. J Clin Oncol. 2026;44(3):200\u201351. https:\/\/doi.org\/10.1200\/JCO-25-02115.","journal-title":"J Clin Oncol."},{"issue":"10","key":"20101_CR16","doi-asserted-by":"publisher","first-page":"e1883","DOI":"10.1002\/onco.13941","volume":"26","author":"A Mittra","year":"2021","unstructured":"Mittra A, Naqash AR, Murray JH, et al. Outcomes of pregnancy during immunotherapy treatment for cancer: analysis of clinical trials sponsored by the National Cancer Institute. Oncologist. 2021;26(10):e1883\u20136. https:\/\/doi.org\/10.1002\/onco.13941.","journal-title":"Oncologist."},{"issue":"3","key":"20101_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1053\/j.seminoncol.2018.06.001","volume":"45","author":"M Burotto","year":"2018","unstructured":"Burotto M, Gormaz JG, Samtani S, et al. Viable pregnancy in a patient with metastatic melanoma treated with double checkpoint immunotherapy. Semin Oncol. 2018;45(3):164\u20139. https:\/\/doi.org\/10.1053\/j.seminoncol.2018.06.001.","journal-title":"Semin Oncol."},{"key":"20101_CR18","unstructured":"National Cancer Institute. Breast Cancer Treatment During Pregnancy (PDQ\u00ae)\u2013Health Professional Version. Updated 2025. Accessed June 2026. https:\/\/www.cancer.gov\/types\/breast\/hp\/pregnancy-breast-treatment-pdq"},{"key":"20101_CR19","doi-asserted-by":"crossref","first-page":"723693","DOI":"10.3389\/fonc.2021.723693","volume":"11","author":"F Poggio","year":"2021","unstructured":"Poggio F, Lambertini M, Bighin C, Peccatori FA, Azim HA, Del Mastro L. Management of breast cancer during pregnancy. Front Oncol. 2021;11:723693.","journal-title":"Front Oncol."},{"key":"20101_CR20","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf"},{"issue":"2","key":"20101_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10549-018-05083-x","volume":"174","author":"ALV Johansson","year":"2019","unstructured":"Johansson ALV, Weibull CE, Fredriksson I, Lambe M. Diagnostic pathways and management in women with pregnancy-associated breast cancer (PABC): no evidence of treatment delays following a first healthcare contact. Breast Cancer Res Treat. 2019;174(2):489\u2013503. https:\/\/doi.org\/10.1007\/s10549-018-05083-x.","journal-title":"Breast Cancer Res Treat."},{"key":"20101_CR22","unstructured":"Associazione Italiana di Oncologia Medica (AIOM). Breast Neoplasms: AIOM Clinical Practice Guidelines. 2018."},{"issue":"5","key":"20101_CR23","first-page":"312","volume":"66","author":"P Bhardwaj","year":"2016","unstructured":"Bhardwaj P, Thakur B, Sharma A. Breast cancer during pregnancy: a review. J Obstet Gynaecol India. 2016;66(5):312\u20138.","journal-title":"J Obstet Gynaecol India."},{"issue":"6","key":"20101_CR24","first-page":"798","volume":"34","author":"FA Peccatori","year":"2023","unstructured":"Peccatori FA, Azim HA Jr, Orecchia R, et al. Breast cancer diagnosed during pregnancy: a multidisciplinary approach. Ann Oncol. 2023;34(6):798\u2013806.","journal-title":"Ann Oncol."},{"issue":"suppl 6","key":"20101_CR25","doi-asserted-by":"publisher","first-page":"vi160","DOI":"10.1093\/annonc\/mdt199","volume":"24","author":"FA Peccatori","year":"2013","unstructured":"Peccatori FA, Azim HA Jr, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(suppl 6):vi160\u201370. https:\/\/doi.org\/10.1093\/annonc\/mdt199.","journal-title":"Ann Oncol."},{"issue":"3","key":"20101_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jamasurg.2013.3049","volume":"149","author":"S Agarwal","year":"2014","unstructured":"Agarwal S, Pappas L, Neumayer L, Kokeny K, Agarwal J. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg. 2014;149(3):267\u201374. https:\/\/doi.org\/10.1001\/jamasurg.2013.3049.","journal-title":"JAMA Surg."},{"key":"20101_CR27","unstructured":"American Society of Breast Surgeons. Neoadjuvant Systemic Therapy in the Management of Breast Cancer: Performance and Practice Guideline. 2018. https:\/\/www.breastsurgeons.org\/docs\/statements\/asbrs-neoadjuvant-systemic-therapy.pdf"},{"issue":"9","key":"20101_CR28","first-page":"3011","volume":"21","author":"A Toesca","year":"2014","unstructured":"Toesca A, Gentilini O, Peccatori FA, Azim HA, Amant F, Locatelli M, Veronesi U. Locoregional treatment of breast cancer during pregnancy. Ann Surg Oncol. 2014;21(9):3011\u20138.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"20101_CR29","first-page":"1296","volume":"14","author":"CH Flores-Balc\u00e1zar","year":"2018","unstructured":"Flores-Balc\u00e1zar CH, Flores-Luna ML, Villarreal-Garza CM, Bargall\u00f3-Rocha JE. Impact of delayed adjuvant radiotherapy on the survival of women with operable breast cancer. J Cancer Res Ther. 2018;14(6):1296\u2013301.","journal-title":"J Cancer Res Ther."},{"key":"20101_CR30","doi-asserted-by":"crossref","unstructured":"American Journal of Obstetrics & Gynecology MFM. Screening for small-for-gestational-age fetuses in early versus late third-trimester ultrasonography. AJOG MFM. 2023;5(6):1009\u20131016.","DOI":"10.1016\/j.ajogmf.2023.101162"},{"issue":"18","key":"20101_CR31","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.ejca.2010.09.010","volume":"46","author":"F Amant","year":"2010","unstructured":"Amant F, Deckers S, Van Calsteren K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer. 2010;46(18):3158\u201368.","journal-title":"Eur J Cancer."},{"issue":"10","key":"20101_CR32","first-page":"902","volume":"37","author":"N Biglia","year":"2011","unstructured":"Biglia N, Ponzone R, Mariani L, Maggiorotto F, Benevelli C, Sismondi P, Robba E. Time to radiotherapy after breast-conserving surgery and outcome in patients with breast cancer. Eur J Surg Oncol. 2011;37(10):902\u20137.","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"20101_CR33","first-page":"24","volume":"16","author":"JS Jeruss","year":"2009","unstructured":"Jeruss JS, Bevers TB, Woodward WA. Management of breast cancer during pregnancy. Ann Surg Oncol. 2009;16(1):24\u201330.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"20101_CR34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4065\/mcp.2011.0141","volume":"86","author":"S Pruthi","year":"2011","unstructured":"Pruthi S, Boughey JC, Brandt KR, et al. Breast cancer and pregnancy: multidisciplinary management. Mayo Clin Proc. 2011;86(4):364\u201371.","journal-title":"Mayo Clin Proc."},{"issue":"12","key":"20101_CR35","first-page":"e560","volume":"16","author":"S Loibl","year":"2015","unstructured":"Loibl S, Schmidt A, Gentilini O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients. Lancet Oncol. 2015;16(12):e560\u201370.","journal-title":"Lancet Oncol."},{"issue":"6","key":"20101_CR36","first-page":"606","volume":"14","author":"M Boyle","year":"2008","unstructured":"Boyle M, Pritchard S. Anaphylaxis to patent blue dye during sentinel lymph node biopsy. Breast J. 2008;14(6):606\u20137.","journal-title":"Breast J."},{"issue":"6","key":"20101_CR37","first-page":"467","volume":"19","author":"MRS Keshtgar","year":"2010","unstructured":"Keshtgar MRS, Ell PJ. Sentinel lymph node biopsy in breast cancer. The Breast. 2010;19(6):467\u201375.","journal-title":"The Breast."},{"issue":"suppl 5","key":"20101_CR38","doi-asserted-by":"publisher","first-page":"v266","DOI":"10.1093\/annonc\/mdq198","volume":"21","author":"FA Peccatori","year":"2010","unstructured":"Peccatori FA, Azim HA Jr, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl 5):v266\u201373. https:\/\/doi.org\/10.1093\/annonc\/mdq198.","journal-title":"Ann Oncol."},{"issue":"25","key":"20101_CR39","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.1080\/14767058.2021.1966410","volume":"35","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang Y, Yang H, Xu Y. Maternal-fetal transfer of indocyanine green: a systematic review. J Matern Fetal Neonatal Med. 2022;35(25):8181\u20135. https:\/\/doi.org\/10.1080\/14767058.2021.1966410.","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"1","key":"20101_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13017-025-00575-w","volume":"20","author":"B De Simone","year":"2025","unstructured":"De Simone B, Abu-Zidan FM, Boni L, et al. Indocyanine green fluorescence-guided surgery in the emergency setting: the WSES international consensus position paper. World J Emerg Surg. 2025;20(1):13. https:\/\/doi.org\/10.1186\/s13017-025-00575-w.","journal-title":"World J Emerg Surg."},{"key":"20101_CR41","unstructured":"U.S. Food and Drug Administration. Magtrace and Sentimag Magnetic Localization System: Summary of Safety and Effectiveness Data (PMA P160053\/S002). Published December 6, 2022. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160053S002B.pdf"},{"issue":"1","key":"20101_CR42","first-page":"e18","volume":"52","author":"MP Rojas","year":"2025","unstructured":"Rojas MP, Sheth N, Halabi S, et al. Patterns of pregnancy-associated breast cancer and outcomes by BRCA status: a retrospective analysis. Semin Oncol. 2025;52(1):e18\u201327.","journal-title":"Semin Oncol."},{"key":"20101_CR43","unstructured":"National Cancer Institute. BRCA Gene Mutations: Cancer Risk and Genetic Testing. Updated July 30, 2024. Accessed March 2025."},{"issue":"6","key":"20101_CR44","first-page":"798","volume":"34","author":"FA Peccatori","year":"2023","unstructured":"Peccatori FA, Azim HA Jr, Orecchia R, et al. Management of breast cancer during pregnancy: multidisciplinary recommendations. Ann Oncol. 2023;34(6):798\u2013806.","journal-title":"Ann Oncol."},{"issue":"1","key":"20101_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jama.2023.25463","volume":"331","author":"M Lambertini","year":"2024","unstructured":"Lambertini M, et al. Pregnancy after breast cancer in young BRCA carriers: an international hospital-based cohort study. JAMA. 2024;331(1):49\u201359. https:\/\/doi.org\/10.1001\/jama.2023.25463.","journal-title":"JAMA."},{"issue":"2","key":"20101_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2(2):127\u201337.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"20101_CR47","doi-asserted-by":"publisher","unstructured":"Loibl S, Andr\u00e9 F, Bachelot T, et al; ESMO Guidelines Committee. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024;35(2):159\u2013182. https:\/\/doi.org\/10.1016\/j.annonc.2023.11.016.","DOI":"10.1016\/j.annonc.2023.11.016"},{"issue":"8","key":"20101_CR48","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrc3309","volume":"12","author":"Y Yarden","year":"2010","unstructured":"Yarden Y, Pines G. The ERBB network: at last, cancer therapy meets systems biology. Nat Rev Cancer. 2010;12(8):553\u201363.","journal-title":"Nat Rev Cancer."},{"issue":"9","key":"20101_CR49","first-page":"791","volume":"13","author":"L Gianni","year":"2012","unstructured":"Gianni L, Pienkowski T, Im Y-H, et al. 5-year analysis of neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (NeoSphere): a randomised phase 2 trial. Lancet Oncol. 2012;13(9):791\u2013800.","journal-title":"Lancet Oncol."},{"issue":"7","key":"20101_CR50","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa1814017","volume":"380","author":"G von Minckwitz","year":"2019","unstructured":"von Minckwitz G, et al. Trastuzumab emtansine for residual invasive HER2-positive breast cancer (KATHERINE). N Engl J Med. 2019;380(7):617\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1814017.","journal-title":"N Engl J Med."},{"issue":"2","key":"20101_CR51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10549-012-2368-y","volume":"137","author":"F Zagouri","year":"2013","unstructured":"Zagouri F, Sergentanis TN, Chrysikos D, Papadimitriou CA, Dimopoulos MA, Bartsch R. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137(2):349\u201357.","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"20101_CR52","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12885-021-08162-3","volume":"21","author":"A Andrikopoulou","year":"2021","unstructured":"Andrikopoulou A, Apostolidou K, Chatzinikolaou S, Rodolakis A, Papadimitriou CA, Sergentanis TN, Zagouri F. Trastuzumab administration during pregnancy: maternal and fetal outcomes. BMC Cancer. 2021;21(1):463.","journal-title":"BMC Cancer."},{"issue":"9643","key":"20101_CR53","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(08)61114-5","volume":"372","author":"MJ Piccart-Gebhart","year":"2008","unstructured":"Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer (HERA trial): 4-year follow-up of a multicentre, open-label, randomised controlled trial. Lancet. 2008;372(9643):1030\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(08)61114-5.","journal-title":"Lancet."},{"issue":"5","key":"20101_CR54","first-page":"649","volume":"118","author":"IT Aldoss","year":"2018","unstructured":"Aldoss IT, Giri S, Malik N, Sardesai SD. Impact of timing of trastuzumab initiation after surgery on outcomes in HER2-positive breast cancer. Br J Cancer. 2018;118(5):649\u201356.","journal-title":"Br J Cancer."},{"key":"20101_CR55","doi-asserted-by":"crossref","first-page":"10384267","DOI":"10.3389\/fendo.2023.1219018","volume":"14","author":"X Bian","year":"2023","unstructured":"Bian X, Shi J, Wang Z, Li Y. Triple-negative breast cancer: biology, mechanisms, and therapeutic targets. Front Endocrinol. 2023;14:10384267.","journal-title":"Front Endocrinol."},{"key":"20101_CR56","unstructured":"Santa-Maria CA; National Comprehensive Cancer Network. Breast Cancer: NCCN Clinical Practice Guidelines in Oncology Summary (NCCN BC24). Version 1.2024. National Comprehensive Cancer Network; 2024."},{"key":"20101_CR57","doi-asserted-by":"publisher","unstructured":"Schmid P, Cortes J, Pusztai L, et al; KEYNOTE-522 Investigators. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020;382(9):810\u2013821. https:\/\/doi.org\/10.1056\/NEJMoa1910549.","DOI":"10.1056\/NEJMoa1910549"},{"issue":"5","key":"20101_CR58","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.21037\/jtd.2018.04.94","volume":"10","author":"S Li","year":"2018","unstructured":"Li S, Ma D, Shi H-H, Yu K-D, Zhang Q. The impact of delayed adjuvant chemotherapy on relapse of triple-negative breast cancer. J Thorac Dis. 2018;10(5):2837\u201341.","journal-title":"J Thorac Dis."},{"issue":"4","key":"20101_CR59","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/tbj.13625","volume":"26","author":"D Livingston-Rosanoff","year":"2020","unstructured":"Livingston-Rosanoff D, Hanlon B, Marka N, et al. Time to initiation of neoadjuvant chemotherapy for breast cancer treatment does not influence patient survival: a study of US breast cancer patients. Breast J. 2020;26(4):625\u20139.","journal-title":"Breast J."},{"issue":"41","key":"20101_CR60","doi-asserted-by":"publisher","first-page":"e40059","DOI":"10.1097\/MD.0000000000040059","volume":"103","author":"W Bao","year":"2024","unstructured":"Bao W, Ma X, Xue Y, Zou X, Guo Y. Pregnancy-associated triple-negative breast cancer: a case report and literature review. Medicine (Baltimore). 2024;103(41):e40059. https:\/\/doi.org\/10.1097\/MD.0000000000040059.","journal-title":"Medicine (Baltimore)."},{"issue":"22","key":"20101_CR61","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","volume":"376","author":"N Masuda","year":"2017","unstructured":"Masuda N, Lee S-J, Ohtani S, et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376(22):2147\u201359.","journal-title":"N Engl J Med."},{"key":"20101_CR62","doi-asserted-by":"publisher","first-page":"103494","DOI":"10.1016\/j.critrevonc.2021.103494","volume":"168","author":"CFJ Bakhuis","year":"2021","unstructured":"Bakhuis CFJ, Suelmann BBM, van Dooijeweert C, et al. Receptor status of breast cancer diagnosed during pregnancy: a literature review. Crit Rev Oncol Hematol. 2021;168:103494.","journal-title":"Crit Rev Oncol Hematol."},{"issue":"1","key":"20101_CR63","first-page":"103","volume":"191","author":"J Fu","year":"2022","unstructured":"Fu J, Zhang Q, Liu L, Rao W, Ma D, Zhou Y, Li X. Impact of delayed initiation of endocrine therapy on survival in hormone receptor\u2013positive breast cancer. Breast Cancer Res Treat. 2022;191(1):103\u201315.","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"20101_CR64","first-page":"11","volume":"170","author":"C Duggan","year":"2018","unstructured":"Duggan C, Tighe S, O\u2019Neill AJ. Multigene expression assays in hormone receptor\u2013positive breast cancer: a clinical review. Breast Cancer Res Treat. 2018;170(1):11\u201323.","journal-title":"Breast Cancer Res Treat."},{"issue":"16","key":"20101_CR65","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1200\/JCO.22.00069","volume":"40","author":"F Andre","year":"2022","unstructured":"Andre F, Ismaila N, Allison KH, et al. Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO guideline update. J Clin Oncol. 2022;40(16):1816\u201337. https:\/\/doi.org\/10.1200\/JCO.22.00069.","journal-title":"J Clin Oncol."},{"issue":"1","key":"20101_CR66","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJMoa1804710","volume":"380","author":"JA Sparano","year":"2019","unstructured":"Sparano JA, Gray RJ, Makower DF, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2019;380(1):77\u201392. https:\/\/doi.org\/10.1056\/NEJMoa1804710.","journal-title":"N Engl J Med."},{"issue":"1","key":"20101_CR67","first-page":"1","volume":"197","author":"B Giachetti","year":"2023","unstructured":"Giachetti B, Sarotto I, Santoro A, Cirillo L, Manes G, Giordano S. Clinical utility of multigene expression assays in special populations including pregnancy: a systematic review. Breast Cancer Res Treat. 2023;197(1):1\u201312.","journal-title":"Breast Cancer Res Treat."},{"issue":"11","key":"20101_CR68","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1001\/jamaoncol.2016.0580","volume":"2","author":"LM Spring","year":"2016","unstructured":"Spring LM, Gupta A, Reynolds KL, et al. Neoadjuvant endocrine therapy for estrogen receptor\u2013positive breast cancer: a systematic review and meta-analysis. JAMA Oncol. 2016;2(11):1477\u201386. https:\/\/doi.org\/10.1001\/jamaoncol.2016.0580.","journal-title":"JAMA Oncol."},{"issue":"2","key":"20101_CR69","first-page":"e90","volume":"13","author":"HA Azim Jr","year":"2012","unstructured":"Azim HA Jr, Santoro L, Brohee S, et al. Pregnancy and breast cancer: a systematic review of published evidence. Lancet Oncol. 2012;13(2):e90\u20138.","journal-title":"Lancet Oncol."},{"issue":"2","key":"20101_CR70","first-page":"343","volume":"178","author":"J Li","year":"2019","unstructured":"Li J, Chen S, Xu H, et al. Effect of delayed initiation of adjuvant hormone therapy on survival in patients with hormone receptor\u2013positive breast cancer. Breast Cancer Res Treat. 2019;178(2):343\u201353.","journal-title":"Breast Cancer Res Treat."},{"issue":"3","key":"20101_CR71","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10549-021-06130-w","volume":"186","author":"BBM Suelmann","year":"2021","unstructured":"Suelmann BBM, van Dooijeweert C, van der Wall E, Linn S, van Diest PJ. Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile. Breast Cancer Res Treat. 2021;186(3):699\u2013704.","journal-title":"Breast Cancer Res Treat."},{"issue":"2","key":"20101_CR72","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jso.70010","volume":"132","author":"K Varagur","year":"2025","unstructured":"Varagur K, Ribaudo JG, Keller M, et al. Understanding trends in incidence and management of pregnancy-associated breast cancer in a national sample using claims data. J Surg Oncol. 2025;132(2):323\u201333. https:\/\/doi.org\/10.1002\/jso.70010.","journal-title":"J Surg Oncol."},{"key":"20101_CR73","doi-asserted-by":"publisher","unstructured":"Armstrong A, Gandhi A, Frank S, Williams D, Nimalasena S; Royal College of Obstetricians and Gynaecologists. Pregnancy and breast cancer: Green-top Guideline No. 12. BJOG. 2025;132(12):e194\u2013e228. https:\/\/doi.org\/10.1111\/1471-0528.18270.","DOI":"10.1111\/1471-0528.18270"},{"key":"20101_CR74","doi-asserted-by":"crossref","unstructured":"Calvillo KM, Bevilacqua JL, Levine JL, Peled AW. Immediate tissue expander reconstruction in pregnancy-associated breast cancer. J Clin Oncol. 2013;31(15_suppl):1133.","DOI":"10.1200\/jco.2013.31.15_suppl.1133"},{"issue":"6","key":"20101_CR75","first-page":"1218","volume":"22","author":"P Gdalevitch","year":"2013","unstructured":"Gdalevitch P, Ho AL, Genoway K, Arnaout A, Zhong T. Breast reconstruction during pregnancy: a case series and review of the literature. The Breast. 2013;22(6):1218\u201322.","journal-title":"The Breast."},{"key":"20101_CR76","doi-asserted-by":"publisher","first-page":"1332862","DOI":"10.3389\/fonc.2023.1332862","volume":"13","author":"A Innocenti","year":"2024","unstructured":"Innocenti A, Susini P, Grimaldi L, Susini T. Breast cancer in pregnancy: concurrent cesarean section, nipple-sparing mastectomy, and immediate breast reconstruction: case report. Front Oncol. 2024;13:1332862. https:\/\/doi.org\/10.3389\/fonc.2023.1332862.","journal-title":"Front Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20101-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20101-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20101-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:53:09Z","timestamp":1789667589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20101-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20101"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20101-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}